Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             169 results found
no title author magazine year volume issue page(s) type
1 A bacterial surface-expression system using OmpA fusion-proteins.4 1996
 2 4 p. 283-284
2 p.
 article
2 Activity of monoclonal antibodies in prevention of in vitro aggregation of their antigens 1996
 2 4 p. 305-
1 p.
 article
3 Affinity maturation and structural analysis of a humanized antibody 1996
 2 4 p. 276-
1 p.
 article
4 Altered binding energetics of the M3 mutant of antibody D1.3 selected by phage display for enhanced binding to hen egg lysozyme 1996
 2 4 p. 282-283
2 p.
 article
5 A molecular model for an antibody that binds Lex and sialyl Lex 1996
 2 4 p. 278-
1 p.
 article
6 A monoclonal antibody that blocks HIV-I gp120 glycoprotein binding to neurons 1996
 2 4 p. 301-
1 p.
 article
7 An antibody against a specific peptide/MHC class I complex 1996
 2 4 p. 312-
1 p.
 article
8 An expression system for catalytic anti-bodies: characterization and applications 1996
 2 4 p. 293-
1 p.
 article
9 A novel strategy to reduce anti-idiotypic responses to campath-1 1996
 2 4 p. 272-273
2 p.
 article
10 An overview of the 1996 keystone meeting exploring and exploiting antibody and Ig superfamily combining sites Huston, James S
 1996
 2 4 p. 253-260
8 p.
 article
11 Antibodies against crystals 1996
 2 4 p. 289-
1 p.
 article
12 Antibodies as modulators of protein activities — implications for intravenous therapy 1996
 2 4 p. 283-
1 p.
 article
13 Antibodies for immunosuppression and tolerance — A war analogy 1996
 2 4 p. 272-
1 p.
 article
14 Anti EGP-2 phage antibodies as a tool for identifying novel colon tumor antigens. [Abst. 223] 1996
 2 4 p. 290-
1 p.
 article
15 Antigen binding peptides derived from long random peptide phage libraries mimic antibodies and can generate mimetopes 1996
 2 4 p. 297-
1 p.
 article
16 Antigen-binding sites dominate the surface properties of antibodies 1996
 2 4 p. 276-
1 p.
 article
17 Antigen presentation of a T cell epitope inserted at different positions in an antibody heavy chain 1996
 2 4 p. 305-
1 p.
 article
18 Antimalarial antibodies produced by recombinant phage display 1996
 2 4 p. 299-300
2 p.
 article
19 Association of murine monoclonal antibody HyHEL-5 with lysozyme: biophysical characterization 1996
 2 4 p. 281-
1 p.
 article
20 Author index volume 2 (1996) 1996
 2 4 p. 315-316
2 p.
 article
21 Bacterial expression of a human Fv fragment IgM with a novel antibody combining site 1996
 2 4 p. 280-
1 p.
 article
22 B-cell superantigens: molecular, cellular and in vivo consequences 1996
 2 4 p. 268-269
2 p.
 article
23 Binary toxins for targeting cancer cells. [Abst. L01] 1996
 2 4 p. 312-
1 p.
 article
24 Binding is not enough for catalysis 1996
 2 4 p. 294-295
2 p.
 article
25 Bispecific antibody (ANTI-C3d/60.3), compensates, in vitro, for the elastase-mediated opsonin-receptor mismatch of cystic fibrosis 1996
 2 4 p. 303-
1 p.
 article
26 ‘Camelising’ human VH domains for use as small recognition units. [Abst. 207] 1996
 2 4 p. 285-
1 p.
 article
27 C-CAM mediates adhesion through a homophilic domain 1/domain 1 interaction in transfected CHO cells 1996
 2 4 p. 311-
1 p.
 article
28 Cellular basis of transplant-associated arteriosclerosis in genetically altered mice 1996
 2 4 p. 275-
1 p.
 article
29 Characterisation of the binding sites of polyamine specific antibodies 1996
 2 4 p. 277-
1 p.
 article
30 Characteristics of human anti-gal genes 1996
 2 4 p. 294-
1 p.
 article
31 Characterization of anti-U1 RNA Fab isolated from bacteriophage display libraries 1996
 2 4 p. 275-276
2 p.
 article
32 Characterization of ScFv antibodies against the human TSH-receptor derived from phage display libraries 1996
 2 4 p. 293-294
2 p.
 article
33 Chimerism after organ transplantation — the mechanism of graft acceptance 1996
 2 4 p. 275-
1 p.
 article
34 Clinical imaging with a single chain Fv anti-CEA, potential for application to antibody directed enzyme prodrug therapy 1996
 2 4 p. 267-
1 p.
 article
35 Comparative protein modeling by satisfaction of spatial restraints 1996
 2 4 p. 279-280
2 p.
 article
36 Comparison of surface properties of human IgA, IgE, IgG and IgM antibodies with identical different specifities 1996
 2 4 p. 282-
1 p.
 article
37 Comparison of the N10 structural, functional and energetic epitodes of staphylococcal nuclease 1996
 2 4 p. 278-
1 p.
 article
38 Comparisons of expression in procaryotic and eucaryotic hosts of human recombinant Fab molecules 1996
 2 4 p. 289-
1 p.
 article
39 Construction of diabody phage display repertories for the selection of large numbers of bispecific antibody fragments [Abst. 217] 1996
 2 4 p. 288-
1 p.
 article
40 Crystal structure of the Vα domain of a T cell antigen receptor 1996
 2 4 p. 270-
1 p.
 article
41 Cucumber mosaic cucumovirus antibodies from a synthetic phage display library 1996
 2 4 p. 296-
1 p.
 article
42 Database-supported antibody engineering 1996
 2 4 p. 304-
1 p.
 article
43 Defective secretion of VH CDR2 mutant antibodies is characterized by increased association of the mutant heavy chains with molecular chaperones and is not a property of the light chain 1996
 2 4 p. 278-
1 p.
 article
44 Design, expression and 3-D structure of bivalent single chain Ig-like molecules. [Abst. 105] 1996
 2 4 p. 276-277
2 p.
 article
45 Design, expression, structure and immunochemistry of bivalent single chain Ig-like molecules 1996
 2 4 p. 313-314
2 p.
 article
46 Design of specifically-radiolabeled recombinant Fab: A search for Fab that bind the tumor antigens sialy-Lewisx and Thomsen-Friedenreich glycoantigens from phage display libraries 1996
 2 4 p. 279-
1 p.
 article
47 Detecting novel cell surface antigens using phage antibody display 1996
 2 4 p. 302-
1 p.
 article
48 Development of methodologies for the expression of soluble T-cell receptors (TCR) 1996
 2 4 p. 308-
1 p.
 article
49 Display OFT-cell receptors on filamentous phage. [Abst. 409] 1996
 2 4 p. 310-311
2 p.
 article
50 Effects of mutations in the heavy chain CDR3 region on the affinity of an anti-PSA diabody 1996
 2 4 p. 280-281
2 p.
 article
51 Engineering antibodies for tumor targeting using phage display 1996
 2 4 p. 290-291
2 p.
 article
52 Engineering of anti-digoxin anybody combining sites 1996
 2 4 p. 263-264
2 p.
 article
53 Engineering scFvs and kinetic analysis of binding affinity on the BIAcoreTM 1996
 2 4 p. 277-278
2 p.
 article
54 Engineering the antibody combining site for high affinity binding 1996
 2 4 p. 264-
1 p.
 article
55 Enhancing the tumor-specifity of human T cells by the expression of chimeric immunoglobulin/T cell receptor genes 1996
 2 4 p. 303-304
2 p.
 article
56 Eukaryotic expression vectors for the membrane display of single-chain antibodies: their use in the selection of transiently-transfected cells from total populations in culture 1996
 2 4 p. 297-298
2 p.
 article
57 Evaluation of different single chain constructs based on antineuroblastoma mab chCE7 1996
 2 4 p. 304-
1 p.
 article
58 Evidence for distinct contributions of heavy and light chains to the restriction of antibody recognition of the human immunodeficiency virus type-1 principal neutralization determinant 1996
 2 4 p. 306-307
2 p.
 article
59 Exploring and exploiting the anti-tumor monoclonal antibody BR96 1996
 2 4 p. 264-
1 p.
 article
60 Expression of soluble T-cell receptor — leucine zipper fusions 1996
 2 4 p. 309-
1 p.
 article
61 Fine tuning of an antibody binding site by mutagenesis and phage display 1996
 2 4 p. 286-287
2 p.
 article
62 Fv fragment crystal structures of the antibody B1-8 in unliganded form and with bound hapten NIP-CAP; analysis at 2 Å resolution. [Abst. 119] 1996
 2 4 p. 281-
1 p.
 article
63 General features of antibody crystal structures 1996
 2 4 p. 261-
1 p.
 article
64 Generation of a humanized anti-CD40 mab for treatment of autoimmune diseases 1996
 2 4 p. 299-
1 p.
 article
65 Generation of an estradiol specific anti-body by phage display 1996
 2 4 p. 291-292
2 p.
 article
66 Generation of polyclonal and monoclonal catalytic sheep antibodies 1996
 2 4 p. 288-
1 p.
 article
67 Generation of scFv immunotoxin molecules based on anti-B7.1/2 mabs for the treatment of Hodgkin's disease 1996
 2 4 p. 298-
1 p.
 article
68 Generation of synthetic and lymphocyte-derived antibody libraries 1996
 2 4 p. 265-
1 p.
 article
69 Genetically engineered lipid-tagged antibody; use in liposome-based fluoroimmunoassay 1996
 2 4 p. 301-302
2 p.
 article
70 Global changes in amide hydrogen exchange rates for a protein antigen in complex with three different antibodies 1996
 2 4 p. 281-282
2 p.
 article
71 High affinity antibodies against 3-FL (Lex, CD15) from a phage display library 1996
 2 4 p. 313-
1 p.
 article
72 High-affinity recombinant antibodies against neovasculature and extra-cellular matrix antigens 1996
 2 4 p. 267-268
2 p.
 article
73 Human antibodies specific for human TGF-β derived from phage display libraries 1996
 2 4 p. 306-
1 p.
 article
74 Human antibody diversity 1996
 2 4 p. 263-
1 p.
 article
75 Humanization of murine 6G425: An anti-IL-8 monoclonal antibody which blocks binding of IL-8 to human neutrophils 1996
 2 4 p. 286-
1 p.
 article
76 Idiotypes as vaccines for the treatment of B-cell malignancies 1996
 2 4 p. 268-
1 p.
 article
77 Immunoconjugates for therapy of carcinomas 1996
 2 4 p. 273-
1 p.
 article
78 Immunoglobulins and T cell receptors in inflammatory bowel disease 1996
 2 4 p. 306-
1 p.
 article
79 Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity Ressing, Maaike E
 1996
 2 4 p. 241-251
11 p.
 article
80 Implications and applications of monogamous and crosslinking multivalent antibody binding 1996
 2 4 p. 312-
1 p.
 article
81 Induction of anti-carbohydrate immune responses by carbohydrate mimicking peptides 1996
 2 4 p. 309-310
2 p.
 article
82 Influence of affinity, avidity and size on the tumor retention of anti-c-erB-2 single-chain Fv molecules. [Abst. 300] 1996
 2 4 p. 296-
1 p.
 article
83 Inhibition of cyclin D1 oncogene with intracellular single chain antibodies 1996
 2 4 p. 304-305
2 p.
 article
84 Interactions of recombinant Fab with nucleic acid: binding properties and role of heavy chain CDRS 1996
 2 4 p. 287-
1 p.
 article
85 Intracellular antibodies (intrabodies): development and gene therapy potential 1996
 2 4 p. 268-
1 p.
 article
86 Intracellular (PL) antibodies for virus immunotherapy in transgenic plants. [Abst. 304] 1996
 2 4 p. 297-
1 p.
 article
87 Intracellular targeting by anti-p21 ras scFv: A model for anti-tumor therapy. [Abst. 333] 1996
 2 4 p. 306-
1 p.
 article
88 In vitro selection of a high affinity anti-oestradiol antibody using a phage display human antibody library 1996
 2 4 p. 289-290
2 p.
 article
89 In vivo expression of recombinant anti-tumor immunoglobulin-IL-2 fusion protein 1996
 2 4 p. 301-
1 p.
 article
90 In vivo selection of a lupus phage-display Fv library 1996
 2 4 p. 295-296
2 p.
 article
91 Isolated Ig superfamily domain units: MHC and beyond 1996
 2 4 p. 271-272
2 p.
 article
92 Isolation and characterization of antibody fragments directed to disease markers isolated from patient derived combinatorial libraries 1996
 2 4 p. 287-
1 p.
 article
93 Isolation and characterization of human single chain Fv (scFv) against botulinum neurotoxin type A 1996
 2 4 p. 283-
1 p.
 article
94 Isolation and partial characterization of human antibody fragments specific for group B Streptococcal (GBS) type III capsular polysaccharide isolated by phage display 1996
 2 4 p. 285-
1 p.
 article
95 Isolation of cross-reactive anti-tetanus and anti-melittin antibodies by phage display 1996
 2 4 p. 294-
1 p.
 article
96 Isolation of high affinity and specificity testosterone binding antibodies from a phage display library 1996
 2 4 p. 292-293
2 p.
 article
97 Isolation of human antibodies with sub-nanomolar affinities directly from a large non-immunized phage display library 1996
 2 4 p. 294-
1 p.
 article
98 Isolation of novel tumor antigens using antibody phage display 1996
 2 4 p. 288-289
2 p.
 article
99 Leucine zipper dimerized bivalent and bispecific SCFV antibodies from a phage display library. [Abst. 308] 1996
 2 4 p. 298-299
2 p.
 article
100 Macaque anti-human antibodies: analysis of the host response to a therapeutic humanized antibody 1996
 2 4 p. 300-301
2 p.
 article
101 Mammalian expression and characterization of a dimeric single chain antibody specific for integrin avβ3 1996
 2 4 p. 297-
1 p.
 article
102 Molecular analysis of the function of the human IGA FC domain 1996
 2 4 p. 308-309
2 p.
 article
103 Molecular basis of antigen mimicry by an anti-idiotopic antibody 1996
 2 4 p. 263-
1 p.
 article
104 Molecular characterization of the antigen binding domain of a human natural anti-F(ab′)2 auto-antibody 1996
 2 4 p. 295-
1 p.
 article
105 Molecular recognition of antigen involves CD4/MHC class II/TCR lattice formation on the surface of helper T lymphocytes 1996
 2 4 p. 271-
1 p.
 article
106 Monoclonal antibodies to a seminoma specific antigen 1996
 2 4 p. 303-
1 p.
 article
107 Monoclonal antibodies to fimbriae inhibit proteusmirabilis attachment and invasion in vitro 1996
 2 4 p. 296-297
2 p.
 article
108 Multicombinatorial libraries: new vectors and easy access to very large repertories 1996
 2 4 p. 292-
1 p.
 article
109 Novel immunogen structures and immunization strategies induce antibodies to conserved epitopes of cannabinoids 1996
 2 4 p. 290-
1 p.
 article
110 Nuclear localization of autoantibodies: novel insights into protein translocation and cellular function 1996
 2 4 p. 302-303
2 p.
 article
111 Oligosaccharide epitopes and antibody binding sites of Fab and single chain Fv molecules 1996
 2 4 p. 262-
1 p.
 article
112 Optimisation of the design of recombinant single-chain Fv fragments of antibody molecules 1996
 2 4 p. 267-
1 p.
 article
113 Optimization of catalysis and cytotoxicity 1996
 2 4 p. 266-
1 p.
 article
114 Polyreactive immunoglobulins display diversity in binding site topology 1996
 2 4 p. 279-
1 p.
 article
115 Preclinical development of huNR-LU-10, a humanized antibody for tumor targeting 1996
 2 4 p. 300-
1 p.
 article
116 Preclinical models for targeted therapy 1996
 2 4 p. 266-
1 p.
 article
117 Production and characterization of novel tetravalent bispecific antibodies 1996
 2 4 p. 298-
1 p.
 article
118 Properties of scFv proteins exhibiting specific binding to the plant enzyme enoyl acyl carrier portein reductase 1996
 2 4 p. 293-
1 p.
 article
119 Protein engineering: redesigning of the antibody combining site 1996
 2 4 p. 291-
1 p.
 article
120 Radiochemistry in antibody targeting 1996
 2 4 p. 265-266
2 p.
 article
121 Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis 1996
 2 4 p. 272-
1 p.
 article
122 Rational modification of antibodies and T-cell receptors 1996
 2 4 p. 269-
1 p.
 article
123 Rational mutation of a catalytic antibody 1996
 2 4 p. 291-
1 p.
 article
124 Recombinant forms of a T-cell specific IGM 1996
 2 4 p. 309-
1 p.
 article
125 Recombinant human antibodies against the Plasmodium falciparum glutamate rich protein 1996
 2 4 p. 299-
1 p.
 article
126 Recombinant human HLA-DR1 class II MHC molecules as biologically active covalently-linked heterotrimers of antigenic peptide, beta chain and alpha chain 1996
 2 4 p. 310-
1 p.
 article
127 Recombinant TNF-B1 (Fv) fusion protein selectively kills LEY-antigen expressing TNF-α sensitive human cancer cells 1996
 2 4 p. 305-
1 p.
 article
128 Redirected cellular cytotoxicity mediated by bispecific antibodies 1996
 2 4 p. 266-
1 p.
 article
129 Remodeling of a catalytic antibody through mutagenesis and selection 1996
 2 4 p. 266-267
2 p.
 article
130 Residues near the amino termini contribute to hapten recognition in a cloned anti-17β-estradiol Fab fragment 1996
 2 4 p. 280-
1 p.
 article
131 R/K residues located in the middle positions of peptide where side chains protrude towards the solvent may directly prevent HLA-A11 specific antibody, AUF5.13, from binding to the complexes 1996
 2 4 p. 311-312
2 p.
 article
132 Role of chain pairing and peptide occupancy for the production of functional soluble IA MHC class II molecules 1996
 2 4 p. 311-
1 p.
 article
133 Role of junctional diversity in anti-DNA antibodies 1996
 2 4 p. 279-
1 p.
 article
134 SCFV antibody fragments for breast tumor targeting 1996
 2 4 p. 285-
1 p.
 article
135 scFv-kappa: A new single-chain antibody format showing increased expression levels in both procaryotic and eucaryotic systems 1996
 2 4 p. 286-
1 p.
 article
136 Selected light chains combine with a given heavy chain to confer anti-M or -N specificity 1996
 2 4 p. 292-
1 p.
 article
137 Selection of bivalent anti-PSA antibody clones from a phage display library 1996
 2 4 p. 302-
1 p.
 article
138 Selection of SCFV fragments against oxygen sensitive reduced flavin 1996
 2 4 p. 284-
1 p.
 article
139 Single chain Fv cytokine fusion proteins as vaccines for B cell lymphoma 1996
 2 4 p. 300-
1 p.
 article
140 Single-chain Fv immunotechnology 1996
 2 4 p. 269-270
2 p.
 article
141 Single-chain immunofusions engineered with human RNases 1996
 2 4 p. 313-
1 p.
 article
142 Single-chain immunotoxins for the treatment of carcinomas and hematologic malignancies 1996
 2 4 p. 274-
1 p.
 article
143 Stabilization of a single-chain FV antibody by introduction of a disulfide bond. [Abst. 338] 1996
 2 4 p. 307-308
2 p.
 article
144 Structure of a humanized anti-lysozyme FV domain. [Abst. 103] 1996
 2 4 p. 276-
1 p.
 article
145 Structures of catalytic and anti-peptide antibody binding sites 1996
 2 4 p. 261-262
2 p.
 article
146 Studies of a phage-derived anti-CEA SCFV obtained fron a combinatorial library 1996
 2 4 p. 265-
1 p.
 article
147 Studies on the interaction of the small organic pesticide molecule atrazine with single-chain antibody fragments 1996
 2 4 p. 286-
1 p.
 article
148 Subject index volume 2 (1996) 1996
 2 4 p. 317-318
2 p.
 article
149 Targeting adenovirus-mediated gene delivery with recombinant antibodies 1996
 2 4 p. 307-
1 p.
 article
150 T cell receptor interactions with photoreactive H-2KDd peptide derivative complexes 1996
 2 4 p. 310-
1 p.
 article
151 Testing of an experimentally supported peptid-Fab-model by site-directed mutagenesis 1996
 2 4 p. 282-
1 p.
 article
152 The analysis of anti-self and antimicrobial antibodies from a patient with SLE obtained from a combinatorial library 1996
 2 4 p. 287-288
2 p.
 article
153 The complete nucleotide sequence of the human immunoglobulin D Segment Locus. [Abst. 100] 1996
 2 4 p. 275-
1 p.
 article
154 The development of recombinant toxins for the treatment of cancer 1996
 2 4 p. 273-274
2 p.
 article
155 The development of the interdomain interface as the recognition structure for FC receptor Ig interaction 1996
 2 4 p. 309-
1 p.
 article
156 The folding pathway of antibodies: in vitro studies by NMR, engineering and selection for better folding 1996
 2 4 p. 269-
1 p.
 article
157 The generation of polyurethane-specific catalytic antibodies 1996
 2 4 p. 292-
1 p.
 article
158 The glycosylated adhesion domain of human CD2: glycan structure and significance for the interaction with CD58 1996
 2 4 p. 262-263
2 p.
 article
159 The role of IGG glycosylation in rheumatoid factor (RF) recognition 1996
 2 4 p. 308-
1 p.
 article
160 The structure and antigen specificity of antibody binding sites can be influenced by clan-specific and family-specific amino acids in heavy chain frameworks 1 and 3. [Abst. 107] 1996
 2 4 p. 277-
1 p.
 article
161 The use of antibody fragments for the sensitive detection and removal of organic pollutants from the environment. [Abst. 337] 1996
 2 4 p. 307-
1 p.
 article
162 Towards sequence-specific antibody proteases: a sensitive assay for peptide-bond hydrolysis 1996
 2 4 p. 284-
1 p.
 article
163 Transplantation without immunosuppression 1996
 2 4 p. 274-
1 p.
 article
164 Using multiple loxP sites to access antibody heaby-light chain combinatorial diversity 1996
 2 4 p. 295-
1 p.
 article
165 Using multiple loxP sites to access antibody heavy-light chain combinatorial diversity 1996
 2 4 p. 264-265
2 p.
 article
166 Utilization of the genetic and structural information on MHC molecules to study autoimmunity and alloreactivity 1996
 2 4 p. 270-271
2 p.
 article
167 Volume contents volume 2 (1996) 1996
 2 4 p. 319-320
2 p.
 article
168 Why are immune reactions to allografts so aggressive? 1996
 2 4 p. 270-
1 p.
 article
169 Yeast surface display system for antibody engineering 1996
 2 4 p. 283-
1 p.
 article
                             169 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands